Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PREMIER Biosoft Acquires ProteoIQ

Published: Tuesday, March 12, 2013
Last Updated: Monday, March 11, 2013
Bookmark and Share
Company adds strength to its mass spectrometry product portfolio with the acquisition of ProteoIQ from NuSep, Australia.

PREMIER Biosoft has announced the acquisition of ProteoIQ from NuSep a publicly listed Australia firm. With ProteoIQ, PREMIER Biosoft now offers a broad spectrum of products for mass spectrometry based "Omics" and "Imaging" studies to the research community.

With this acquisition, PREMIER Biosoft enters the attractive proteomics market, after successfully launching best-in-class products for the lipidomics, glycomics and MALDI imaging markets.

ProteoIQ is a software tool for proteomic data analysis that streamlines the process of statistical validation, protein quantification and comparative proteomics on one platform.

It supports validation of the proteins identified by other database search tools such as Mascot, SEQUEST, or X!Tandem.

ProteoIQ incorporates the False Discovery Rate and Protein Probability approaches for statistical validation of identified proteins.

It performs quantitative analysis via spectral counting, precursor intensity, iTRACQ, TMT, SILAC and iCAT workflows.

Users can quickly perform differential analysis of results across biological samples thereby facilitating identification of putative biomarkers.

"For the rapidly growing proteomics market, ProteoIQ is a strategic fit to PREMIER Biosoft's existing mass spec product offering and helps consolidate our position as a leader for providing informatics tools for mass spectrometry," said Arun Apte, CEO, PREMIER Biosoft.

This is the second acquisition for the company, after completing the acquisition of Redasoft in August 2011.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PREMIER Biosoft and JEOL Enter Agreement
The co-marketing agreement aims to advance research involving marker studies, drug metabolite profiling, lipid and proteomics analysis using MALDI-IMS technology.
Thursday, June 06, 2013
Scientific News
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Enzyme Links Age-Related Inflammation, Cancer
Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
HIV Protein Manipulates Hundreds of Human Genes
Findings search for new or improved treatments for patients with AIDS.
First 3-D Vision of Cancer Target
This basic research set the grounds for structure-based drug design approaches that could be beneficial for cancer treatments' - Dr. Cyril Dominguez, University of Leicester.
New Light Shed on Genetic Regulation
A team of scientists has uncovered greater intricacy in protein signaling than was previously understood, shedding new light on the nature of genetic production.
Hacking the Programs of Cancer Stem Cells
All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!